BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9329389)

  • 1. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
    Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3481-6. PubMed ID: 9329389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.
    Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
    Surgery; 1998 Dec; 124(6):1094-8; discussion 1098-9. PubMed ID: 9854589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
    Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
    World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas.
    Garner SC; Hinson TK; McCarty KS; Leight M; Leight GS; Quarles LD
    Surgery; 1997 Dec; 122(6):1166-75. PubMed ID: 9426434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of parathyroid hormone, parathyroid secretory protein, parathyroid hormone messenger RNA, parathyroid secretory protein mRNA, and replication in human parathyroid adenoma and secondary hyperplasia tissues and cultures.
    Weber CJ; Russell J; Costanzo MK; Karp F; Benjamin M; Hardy MA; Feind CR
    Surgery; 1992 Dec; 112(6):1089-94; discussion 1094-5. PubMed ID: 1455310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
    Levine MA; Dempsey MA; Helman LJ; Ahn TG
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.
    Cetani F; Pinchera A; Pardi E; Cianferotti L; Vignali E; Picone A; Miccoli P; Viacava P; Marcocci C
    J Bone Miner Res; 1999 Jun; 14(6):878-82. PubMed ID: 10352095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus.
    Thompson DB; Samowitz WS; Odelberg S; Davis RK; Szabo J; Heath H
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3377-80. PubMed ID: 7593455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
    Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3.
    Rogers KV; Dunn CK; Conklin RL; Hadfield S; Petty BA; Brown EM; Hebert SC; Nemeth EF; Fox J
    Endocrinology; 1995 Feb; 136(2):499-504. PubMed ID: 7835282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P; Akerstrom G; Westin G
    Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor.
    Szabo E; Carling T; Hessman O; Rastad J
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3961-5. PubMed ID: 12161540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal calcium distribution in human parathyroid adenomas as possible cause of primary hyperparathyroidism.
    Dietel M; Arps H; Niendorf A; Schäfer HJ; Hölzel F
    Horm Metab Res; 1987 Apr; 19(4):177-81. PubMed ID: 3583224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
    Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Ca-dependent change of serum PTH and extracellular Ca2+-sensing receptor expression in parathyroid adenoma.
    Kaneko C; Mizunashi K; Tanaka M; Uzuki M; Kikuchi M; Sawai T; Goto MM
    Calcif Tissue Int; 1999 Mar; 64(3):271-2. PubMed ID: 10024390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.
    Lu M; Berglund E; Larsson C; Höög A; Farnebo LO; Bränström R
    J Endocrinol; 2011 Jan; 208(1):31-9. PubMed ID: 20974637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.